Works matching IS 03065251 AND DT 2023 AND VI 89 AND IP 2

Results: 52

ISSUE HIGHLIGHTS.

Published in:: British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 427, doi. 10.1111/bcp.15656
Publication type:: Article

A critical appraisal of controlled studies investigating malformation risks following pregabalin use in early pregnancy.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 630, doi. 10.1111/bcp.15607

By:

Richardson, Jonathan L.;
Damkier, Per;
Diav‐Citrin, Orna;
George, Nathan;
Greenall, Amanda J.;
Oliver, Alison M.;
Stephens, Sally;
Hodson, Kenneth K.

Publication type:

Article

Guillain‐Barré syndrome after COVID‐19 vaccines: A Tunisian case series.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 574, doi. 10.1111/bcp.15601

By:

Berrim, Khouloud;
Lakhoua, Ghozlane;
Zaiem, Ahmed;
Charfi, Ons;
Aouinti, Imen;
Kastalli, Sarrah;
Daghfous, Riadh;
El Aidli, Sihem

Publication type:

Article

Management of acquired haemophilia A in severe Covid‐19: Haemostatic bridging with emicizumab to keep the balance between bleeding and thrombosis.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 908, doi. 10.1111/bcp.15598

By:

Gelbenegger, Georg;
Traby, Ludwig;
Rahimi, Nina;
Knöbl, Paul

Publication type:

Article

Fomepizole should not be used more liberally in paracetamol overdose.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 599, doi. 10.1111/bcp.15596

By:

Dear, James W.

Publication type:

Article

Fomepizole should be used more liberally in paracetamol overdose.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 594, doi. 10.1111/bcp.15594

By:

Filip, Ari B.;
Mullins, Michael E.

Publication type:

Article

Vaptans for hyponatraemia.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 921, doi. 10.1111/bcp.15593

By:

Tanemoto, Masayuki

Publication type:

Article

Cytochrome P450 inhibition to decrease dosage and costs of venetoclax and ibrutinib: A proof‐of‐concept case study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 898, doi. 10.1111/bcp.15590

By:

De la Garza‐Salazar, Fernando;
Colunga‐Pedraza, Perla Rocío;
Gómez‐Almaguer, David

Publication type:

Article

Case series profile of olanzapine post‐injection delirium/sedation syndrome.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 903, doi. 10.1111/bcp.15588

By:

Seebaluck, Jason;
Downes, Michael A.;
Brown, Jared;
Harris, Keith;
Isoardi, Katherine Z.;
Chan, Betty S.

Publication type:

Article

Clinical efficacy of renal dosing adjustments of ceftazidime–avibactam in patients affected by carbapenem‐resistant Gram‐negative infections: A systematic review and meta‐analysis of observational studies.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 617, doi. 10.1111/bcp.15586

By:

Gatti, Milo;
Fornaro, Giacomo;
Viale, Pierluigi;
Pea, Federico;
Giannella, Maddalena

Publication type:

Article

Quo vadis (where are you going) pharmacovigilance?

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 428, doi. 10.1111/bcp.15584

By:

Kulkarni, Spoorthy;
Rieder, Michael;
Likic, Robert

Publication type:

Article

Do proton pump inhibitors increase the risk of dementia? A systematic review, meta‐analysis and bias analysis.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 602, doi. 10.1111/bcp.15583

By:

Ahn, Nayeon;
Nolde, Michael;
Krause, Evamaria;
Güntner, Florian;
Günter, Alexander;
Tauscher, Martin;
Gerlach, Roman;
Meisinger, Christa;
Linseisen, Jakob;
Baumeister, Sebastian‐Edgar;
Rückert‐Eheberg, Ina‐Maria

Publication type:

Article

Communication is crucial: Lessons from COVID‐19 vaccination and pregnancy.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 582, doi. 10.1111/bcp.15578

By:

Cole, Christine;
Tsakiroglou, Maria;
Waitt, Catriona

Publication type:

Article

COVID‐19 restrictions and the incidence and prevalence of prescription opioid use in Australia – a nationwide study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 914, doi. 10.1111/bcp.15577

By:

Jung, Monica;
Lukose, Dickson;
Nielsen, Suzanne;
Bell, J. Simon;
Webb, Geoffrey I.;
Ilomäki, Jenni

Publication type:

Article

The evolution of pharmacovigilance ecosystems: Does Moore's law invite the use of Occam's razor?

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 470, doi. 10.1111/bcp.15573

By:

Mueller, Marion;
Lewis, David J.;
Alexe, Amalia

Publication type:

Article

Cross‐reactivity between nonsteroidal anti‐inflammatory drugs in fixed drug eruption: Two unusual cases and a literature review.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 561, doi. 10.1111/bcp.15565

By:

Ammar, Helmi;
Ben Fredj, Nadia;
Ben Romdhane, Haifa;
Chaabane, Amel;
Chadli, Zohra;
Ben Fadhel, Najah;
Aouam, Karim

Publication type:

Article

Calcium‐channel blockers: Clinical outcome associations with reported pharmacogenetics variants in 32 000 patients.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 853, doi. 10.1111/bcp.15541

By:

Türkmen, Deniz;
Masoli, Jane A. H.;
Delgado, João;
Kuo, Chia‐Ling;
Bowden, Jack;
Melzer, David;
Pilling, Luke C.

Publication type:

Article

Development and validation of a bleeding risk prediction score for patients with mitral valve stenosis and atrial fibrillation or mechanical heart valves receiving long‐term warfarin therapy.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 843, doi. 10.1111/bcp.15540

By:

Phetroong, Sararat;
Nathisuwan, Surakit;
Chindavijak, Busba;
Phrommintikul, Arintaya;
Sapoo, Ubonwan;
Sookananchai, Bancha;
Priksri, Watcharapong;
Lip, Gregory Y. H.

Publication type:

Article

Quantitative impact of pre‐analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 762, doi. 10.1111/bcp.15536

By:

Maillard, Maud;
Launay, Manon;
Royer, Bernard;
Guitton, Jérôme;
Gautier‐Veyret, Elodie;
Broutin, Sophie;
Tron, Camille;
Le Louedec, Félicien;
Ciccolini, Joseph;
Richard, Damien;
Alarcan, Hugo;
Haufroid, Vincent;
Tafzi, Naïma;
Schmitt, Antonin;
Etienne‐Grimaldi, Marie‐Christine;
Narjoz, Céline;
Thomas, Fabienne

Publication type:

Article

Toxicity signals associated with secukinumab: A pharmacovigilance study based on the United States Food and Drug Administration Adverse Event Reporting System database.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 865, doi. 10.1111/bcp.15535

By:

Zheng, Yi;
Guo, Xiaojing;
Chen, Chenxin;
Chi, Lijie;
Guo, Zhijian;
Liang, Jizhou;
Wei, Lianhui;
Chen, Xiao;
Ye, Xiaofei;
He, Jia

Publication type:

Article

Safety of off‐label dose reduction of non‐vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 751, doi. 10.1111/bcp.15534

By:

van den Dries, Carline J.;
Pajouheshnia, Romin;
van den Ham, Hendrika A.;
Souverein, Patrick;
Moons, Karel G. M.;
Hoes, Arno W.;
Geersing, Geert‐Jan;
van Doorn, Sander

Publication type:

Article

Psychotropic medication in pregnancy and lactation and early development of exposed children.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 737, doi. 10.1111/bcp.15533

By:

Leutritz, Anna Linda;
van Braam, Lara;
Preis, Katharina;
Gehrmann, Andrea;
Scherf‐Clavel, Maike;
Fiedler, Katrin;
Unterecker, Stefan;
Kittel‐Schneider, Sarah

Publication type:

Article

Bleeding events among patients concomitantly treated with direct oral anticoagulants and macrolide or fluoroquinolone antibiotics.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 887, doi. 10.1111/bcp.15531

By:

Yagi, Tatsuya;
Mannheimer, Buster;
Reutfors, Johan;
Ursing, Johan;
Giunta, Diego Hernan;
Kieler, Helle;
Linder, Marie

Publication type:

Article

Revisiting the inter‐rater reliability of drug treatment assessments according to the STOPP/START criteria.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 832, doi. 10.1111/bcp.15530

By:

Parodi López, Naldy;
Belfrage, Björn;
Koldestam, Anders;
Lönnbro, Johan;
Svensson, Staffan A.;
Wallerstedt, Susanna M.

Publication type:

Article

Community pharmacists' participation in adult vaccination: A cross‐sectional survey based on the theoretical domains framework.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 773, doi. 10.1111/bcp.15529

By:

El Hajj, Maguy Saffouh;
Al‐Ziftawi, Nour;
Stewart, Derek;
Al‐Khater, Dhabya Mohamed A. Y.

Publication type:

Article

A single‐centre, open‐label, single‐arm, fixed‐sequence pharmacokinetic study of SHR3680 on repaglinide and bupropion in prostate cancer patients.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 874, doi. 10.1111/bcp.15528

By:

Dai, Tao;
Xu, Zhenzhou;
Huang, Liang;
Wang, Yike;
Zeng, Gongqian;
Ye, Mingji;
Liu, Kan;
Zeng, Fuhua;
Jiang, Shusuan;
Han, Weiqing;
Cao, Jingying

Publication type:

Article

Isoniazid level and flu‐like symptoms during rifapentine‐based tuberculosis preventive therapy: A population pharmacokinetic analysis.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 714, doi. 10.1111/bcp.15527

By:

Lee, Ming‐Chia;
Fujita, Yuito;
Muraki, Shota;
Huang, Hung‐Ling;
Lee, Chih‐Hsin;
Wang, Jann‐Yuan;
Ieiri, Ichiro

Publication type:

Article

A pharmacometrics model to define docetaxel target in early breast cancer.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 727, doi. 10.1111/bcp.15526

By:

Aldaz, Azucena;
Schaiquevich, Paula;
Aramendía, José Manuel

Publication type:

Article

People exposed to proton‐pump inhibitors shortly preceding COVID‐19 diagnosis are not at an increased risk of subsequent hospitalizations and mortality: A nationwide matched cohort study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 787, doi. 10.1111/bcp.15525

By:

Kodvanj, Ivan;
Homolak, Jan;
Trkulja, Vladimir

Publication type:

Article

Prediction of the pharmacokinetics of pemetrexed with a low test dose: A proof‐of‐concept study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 699, doi. 10.1111/bcp.15520

By:

Boosman, René J.;
de Rouw, Nikki;
Huitema, Alwin D. R.;
Burgers, Jacobus A.;
ter Heine, Rob

Publication type:

Article

A stewardship program to facilitate anticholinergic and sedative medication deprescribing using the drug burden index in electronic medical records.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 687, doi. 10.1111/bcp.15517

By:

Masnoon, Nashwa;
Lo, Sarita;
Hilmer, Sarah

Publication type:

Article

Effectiveness of a pharmacist‐led educational intervention on health outcomes in hypertension management at community pharmacies in Nigeria: A two‐arm parallel single‐blind randomized controlled trial.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 649, doi. 10.1111/bcp.15514

By:

Ayogu, Ebere Emilia;
Yahaya, Rahmat Isa;
Isah, Abdulmuminu;
Ubaka, Chukwuemeka Michael

Publication type:

Article

Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 660, doi. 10.1111/bcp.15506

By:

Ibarra, Manuel;
Combs, Ryan;
Taylor, Zachary L.;
Ramsey, Laura B.;
Mikkelsen, Torben;
Buddington, Randal K.;
Heldrup, Jesper;
Barreto, Jason N.;
Guscott, Martin;
Lowe, Jennifer;
Hurmiz, Charles;
Marada, Suresh;
Howard, Scott C.;
Schaiquevich, Paula

Publication type:

Article

Hospital pharmacists' opinions on a risk prediction tool for medication‐related harm in older people.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 672, doi. 10.1111/bcp.15502

By:

Hussain, Ahmed;
Ali, Khalid;
Davies, J. Graham;
Stevenson, Jennifer M.;
Lippett, Samantha;
O'Malley, Mairead;
Parekh, Nikesh;
Rajkumar, Chakravarthi

Publication type:

Article

Cardiovascular complications of modern multiple myeloma therapy: A pharmacovigilance study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 641, doi. 10.1111/bcp.15499

By:

Al‐Yafeai, Zaki;
Ghoweba, Mohamed;
Ananthaneni, Anil;
Abduljabar, Hamzah;
Aziz, David

Publication type:

Article

Ocular disorders associated with PCSK9 inhibitors: A pharmacovigilance disproportionality analysis.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 458, doi. 10.1111/bcp.15494

By:

Zhao, Xiaofang;
Wu, Jiangfan;
Zhu, Shenyin

Publication type:

Article

Dose optimization of cefotaxime as pre‐emptive treatment in critically ill adult patients: A population pharmacokinetic study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 705, doi. 10.1111/bcp.15487

By:

Roelofsen, Eveline E.;
Abdulla, Alan;
Muller, Anouk E.;
Endeman, Henrik;
Gommers, Diederik;
Dijkstra, Annemieke;
Hunfeld, Nicole G. M.;
de Winter, Brenda C. M.;
Koch, Birgit C. P.

Publication type:

Article

Recombinant protein subunit COVID‐19 vaccine‐induced Guillain‐Barré Syndrome in an adolescent: A case report.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 556, doi. 10.1111/bcp.15466

By:

Rohilla, Rachna;
Kakkar, Ashish Kumar;
Divyashree, Krishna;
Mohindra, Ritin;
Suri, Vikas

Publication type:

Article

Roadmap to optimal pharmacovigilance practice in neonatal intensive care units.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 523, doi. 10.1111/bcp.15465

By:

Samiee‐Zafarghandy, Samira;
van den Anker, John;
Allegaert, Karel

Publication type:

Article

Acute appendicitis in a patient immunised with COVID‐19 vaccine: A case report with morphological analysis.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 551, doi. 10.1111/bcp.15421

By:

Marconi, Ettore;
Crescioli, Giada;
Bonaiuti, Roberto;
Pugliese, Lavinia;
Santi, Raffaella;
Nesi, Gabriella;
Cerbai, Elisabetta;
Vannacci, Alfredo;
Lombardi, Niccolò

Publication type:

Article

Cefotaxime‐induced drug reaction with eosinophilia and systemic symptom in a child with cross‐reactivity to other cephalosporins and cosensitization to teicoplanin.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 544, doi. 10.1111/bcp.15419

By:

Mansour, Khadija;
Ben Fadhel, Najah;
Ben Fredj, Nadia;
Ben Romdhane, Haifa;
Chaabane, Amel;
Chadli, Zohra;
Aouam, Karim

Publication type:

Article

Safety of sugammadex for reversal of neuromuscular block: A postmarketing study based on the World Health Organization pharmacovigilance database.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 449, doi. 10.1111/bcp.15417

By:

Lyu, Qiang;
Ye, Pei;
Zhang, Hewei;
Ye, Xiaofei;
Zheng, Yi;
Xu, Jinfang;
Chen, Xiao;
Chen, Chenxin;
Guo, Xiaojing

Publication type:

Article

Central anticholinergic syndrome secondary to atropine eye drops: A case study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 541, doi. 10.1111/bcp.15408

By:

Soletchnik, Mickael;
Rousseau, Geoffroy;
Gonzalez, Lola;
Laribi, Saïd

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 425, doi. 10.1111/bcp.15397
Publication type:: Article

Erythema nodosum induced by Covid‐19 Pfizer‐BioNTech mRNA vaccine: A case report and brief literature review.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 536, doi. 10.1111/bcp.15351

By:

Chahed, Ferdaous;
Ben Fadhel, Najah;
Ben Romdhane, Haifa;
Youssef, Monia;
Ben Hammouda, Seifeddine;
Chaabane, Amel;
Aouam, Karim;
Ben Fredj, Nadia

Publication type:

Article

Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 440, doi. 10.1111/bcp.15336

By:

Wu, Bin;
Shen, Pengfei;
Yin, Xi;
Yu, Lei;
Wu, Fengbo;
Chen, Chen;
Li, Jian;
Xu, Ting

Publication type:

Article

Impact of pharmacist intervention in reducing vancomycin‐associated acute kidney injury: A systematic review and meta‐analysis.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 526, doi. 10.1111/bcp.15301

By:

Kunming, Pan;
Xiaotian, Jiang;
Qing, Xu;
Chenqi, Xu;
Xiaoqiang, Ding;
Qian Zhou, Lv

Publication type:

Article

Pharmacovigilance in China: Evolution and future challenges.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 510, doi. 10.1111/bcp.15277

By:

Song, Haibo;
Pei, Xiaojing;
Liu, Zuoxiang;
Shen, Chuanyong;
Sun, Jun;
Liu, Yuqin;
Zhou, Lingyun;
Sun, Feng;
Xiao, Xiaohe

Publication type:

Article

Cholecystitis and cholangitis associated with lenvatinib: A pharmacovigilance study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 579, doi. 10.1111/bcp.15243

By:

Lu, Wenchao;
Tang, Borui;
Guo, Qixiang;
Zhao, Zhixia;
Liu, Lihong

Publication type:

Article

Pharmacovigilance in low‐ and middle‐income countries: A review with particular focus on Africa.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 491, doi. 10.1111/bcp.15193

By:

Kiguba, Ronald;
Olsson, Sten;
Waitt, Catriona

Publication type:

Article